A look back on the Biden administration’s most significant actions impacting food and farming during the president’s tenure.

The Biden administration's Food and Drug Administration (FDA) released additional details on a proposed rule that would effectively ban cigarettes currently on the market.

The US Food and Drug Administration is proposing limits on the level of nicotine in cigarettes and some other types of tobacco products in order to make them less addictive, the agency announced Wednesday. “If finalized, the United States would be the ...

In the face of an opioid overdose crisis, President Biden oversaw a historic shift toward harm reduction for addiction.

The proposal in the waning days of the Biden administration leaves it up to President-elect Donald Trump to finalize the effort — or scrap it.

A proposed FDA rule would mandate a reduction to minimally addictive or nonaddictive levels, but the incoming Trump administration isn’t expected to follow through on the idea.

WASHINGTON — President Trump began his second term Monday with a sweeping order aimed at reversing dozens of former President Biden’s top priorities, from regulations aimed at lowering health care costs, to coronavirus outreach, Affordable Care Act expansions, and protections against gender-based discrimination.

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid agencies to research and implement models for lowering the costs of prescription drugs. Separate provisions in the Inflation Reduction Act of 2022 also aimed at lower prescription drug costs are still in effect.

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower prescription costs — is befuddling drug pricing experts.

It looks like he’s got one last surprise up his sleeve. There’s a new report that says outgoing President Joe Biden is getting ready to make this one shocking move before leaving office. Keep reading below for everything you need to know.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.

President Trump is rolling back Biden healthcare policies, such as expansions to the Affordable Care Act – a move Democrats described as an "attack" on the federal program.